BSE filing, NSE: INDIAGLYCO. Summary written from the filing by ALFA Finder's alert engine.
India Glycols Ltd: key numbers
- Share price
- ₹331.45
- Market cap
- ₹2,222 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 7.0×Sector 34.1×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Glycols Ltd
All →India Glycols Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
India Glycols Legal & Regulatory
India Glycols received a GST penalty order of ₹0.06 Crore from the Uttarakhand State Tax Officer, which the company intends to appeal.
- Value
- ₹0.06 Cr
- From
- State Tax Officer, SGST Department, Uttarakhand
India Glycols Price Movement Clarification
India Glycols Limited clarified that it has no undisclosed material information regarding recent share price movements. The company attributes the price fluctuation to market-driven factors.
India Glycols Other Announcement
India Glycols Ltd has submitted the quarterly certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. The document was received from its Registrar, MCS Share Transfer Agent.
India Glycols Board Meeting Outcome
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Management Change
India Glycols Ltd announced that four senior management personnel ceased their roles following the effective date of a previously disclosed Scheme of Arrangement.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr